Coherus BioSciences is an innovative oncology company focused on developing and commercializing immunotherapy treatments. Led by its approved PD-1 inhibitor LOQTORZI, the company boasts a robust pipeline of mid-stage clinical candidates targeting various cancers. Coherus aims to expand LOQTORZI's applications in non-small cell lung cancer (NPC) and explore synergistic combinations with its pipeline drugs and industry partners, driving advancements in immuno-oncology.
The Field Reimbursement Manager (FRM) at Coherus Oncology is responsible for minimizing access and reimbursement barriers for patients and providers, proactively educating customers on reimbursement support programs, and analyzing reimbursement issues to support patient drug accessibility. The FRM works within a field-based role, serving as a key contact for reimbursement support-related matters and coordinating cross-functional collaboration.
Coherus BioSciences is an innovative oncology company focused on developing and commercializing immunotherapy treatments. Led by its approved PD-1 inhibitor LOQTORZI, the company boasts a robust pipeline of mid-stage clinical candidates targeting various cancers. Coherus aims to expand LOQTORZI's applications in non-small cell lung cancer (NPC) and explore synergistic combinations with its pipeline drugs and industry partners, driving advancements in immuno-oncology.
Ascendis Pharma